Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids

Experimental Cell Research

Volumn 320, Issue 2, 2014, Pages 329-342

  Carduner, Ludovic ^a   Picot, Cédric R ^a   Leroy Dudal, Johanne ^a   Blay, Lyvia ^a   Kellouche, Sabrina ^a   Carreiras, Franck ^a  

^a UNIVERSITÉ DE CERGY PONTOISE   (France)

Author keywords

Anoikis; ERK1 2; Ovarian cancer; PKC; Quiescence; Spheroids; v integrins

Indexed keywords

CASPASE 3; CD51 ANTIGEN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE C; PROTEIN P130; RETINOBLASTOMA PROTEIN; SYNAPTOPHYSIN;

ANCHORAGE INDEPENDENT GROWTH; ANOIKIS; APOPTOSIS; ARTICLE; ASCITES; CANCER RESISTANCE; CANCER TISSUE; CARCINOMA CELL; CELL ANCHORAGE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUES; TUMOR SPHEROID;

ANOIKIS; ECM; ENDOPLASMIC RETICULUM; ER; ERK1/2; EXTRACELLULAR MATRIX; EXTRACELLULAR SIGNAL-REGULATED KINASE 1/2; FAK; FOCAL ADHESION KINASE; MAPK; MCL-1; MITOGEN-ACTIVATED PROTEIN KINASE; MYELOID CELL LEUKEMIA SEQUENCE 1; OVARIAN CANCER; PARP; PHOSPHOINOSITIDE 3-KINASE; PI3K; PKC; POLY(ADP-RIBOSE) POLYMERASE; PROTEIN KINASE C; QUIESCENCE; RB; RETINOBLASTOMA PROTEIN.; SPHEROIDS; ΑV INTEGRINS;

ADENOCARCINOMA; ANOIKIS; CELL CYCLE CHECKPOINTS; CELL SURVIVAL; ENZYME ACTIVATION; FEMALE; HUMANS; INTEGRIN ALPHAV; MAP KINASE SIGNALING SYSTEM; MIDDLE AGED; OVARIAN NEOPLASMS; PROTEIN KINASE C; SIGNAL TRANSDUCTION; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

EID: 84890856047     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.11.011     Document Type: Article

References (49)

1. Brun J.L., Feyler A., Chene G., Saurel J., Brun G., Hocke C. Long-term results and prognostic factors in patients with epithelial ovarian cancer. Gynecol. Oncol. 2000, 78:21-27.
2. Shield K., Ackland M.L., Ahmed N., Rice G.E. Multicellular spheroids in ovarian cancer metastases: biology and pathology. Gynecol. Oncol. 2009, 113:143-148.
3. Correa R.J., Peart T., Valdes Y.R., DiMattia G.E., Shepherd T.G. Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids. Carcinogenesis 2011, 33:49-58.
4. Davidson B., Berner A., Nesland J.M., Risberg B., Berner H.S., Trope C.G., Kristensen G.B., Bryne M., Ann Florenes V. E-cadherin and alpha-, beta-, and gamma-catenin protein expression is up-regulated in ovarian carcinoma cells in serous effusions. J. Pathol. 2000, 192:460-469.
5. Frisch S.M., Screaton R.A. Anoikis mechanisms. Curr. Opin. Cell Biol. 2001, 13:555-562.
6. Stupack D.G., Cheresh D.A. Get a ligand, get a life: integrins, signaling and cell survival. J. Cell Sci. 2002, 115:3729-3738.
7. Desgrosellier J.S., Barnes L.A., Shields D.J., Huang M., Lau S.K., Prévost N., Tarin D., Shattil S.J., Cheresh D.A. An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression. Nat. Med. 2009, 15:1163-1169.
8. Michels J., O'Neill J.W., Dallman C.L., Mouzakiti A., Habens F., Brimmell M., Zhang K.Y., Craig R.W., Marcusson E.G., Johnson P.W., Packham G. Mcl-1 is required for Akata6 B-lymphoma cell survival and is converted to a cell death molecule by efficient caspase-mediated cleavage. Oncogene 2004, 23:4818-4827.
9. Desgrosellier J.S., Cheresh D.A. Integrins in cancer: biological implications and therapeutic opportunities. Nat. Rev. Cancer 2010, 10:9-22.
10. Meier F., Schittek B., Busch S., Garbe C., Smalley K., Satyamoorthy K., Li G., Herlyn M. The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front. Biosci. 2005, 10:2986-3001.
11. Reyland M.E. Protein kinase C isoforms: multi-functional regulators of cell life and death. Front. Biosci. 2009, 14:2386-2399.
12. Dekker L.V., Palmer R.H., Parker P.J. The protein kinase C and protein kinase C related gene families. Curr. Opin. Struct. Biol. 1995, 5:396-402.
13. Rucci N., DiGiacinto C., Orru L., Millimaggi D., Baron R., Teti A. A novel protein kinase C alpha-dependent signal to ERK1/2 activated by alphaVbeta3 integrin in osteoclasts and in Chinese hamster ovary (CHO) cells. J. Cell Sci. 2005, 118:3263-3275.
14. Kellouche S., Fernandes J., Leroy-Dudal J., Gallet O., Dutoit S., Poulain L., Carreiras F. Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin. Tumour Biol. 2010, 31:129-139.
15. Fukai F., Mashimo M., Akiyama K., Goto T., Tanuma S., Katayama T. Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide. Exp. Cell Res. 1998, 242:92-99.
16. Benard J., Da Silva J., De Blois M.C., Boyer P., Duvillard P., Chiric E., Riou G. Characterization of a human ovarian adenocarcinoma line, IGROV1, in tissue culture and in nude mice. Cancer Res. 1985, 45:4970-4979.
17. Ward B.G., Wallace K., Shepherd J.H., Balkwill F.R. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res. 1987, 47:2662-2667.
18. Cruet-Hennequart S., Maubant S., Luis J., Gauduchon P., Staedel C., Dedhar S. alpha(v) integrins regulate cell proliferation through integrin-linked kinase (ILK) in ovarian cancer cells. Oncogene 2003, 22:1688-1702.
19. Shaw T.J., Senterman M.K., Dawson K., Crane C.A., Vanderhyden B.C. Characterization of intraperitoneal, orthotopic, and metastatic xenograft models of human ovarian cancer. Mol. Ther. 2004, 10:1032-1042.
20. Casey R.C., Burleson K.M., Skubitz K.M., Pambuccian S.E., Oegema T.R., Ruff L.E., Skubitz A.P. Beta 1-integrins regulate the formation and adhesion of ovarian carcinoma multicellular spheroids. Am. J. Pathol. 2001, 159:2071-2080.
21. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
22. Burleson K.M., Casey R.C., Skubitz K.M., Pambuccian S.E., Oegema T.R., Skubitz A.P. Ovarian carcinoma ascites spheroids adhere to extracellular matrix components and mesothelial cell monolayers. Gynecol. Oncol. 2004, 93:170-181.
23. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 1998, 273:18623-18632.
24. Landen C.N., Kim T.J., Lin Y.G., Merritt W.M., Kamat A.A., Han L.Y., Spannuth W.A., Nick A.M., Jennnings N.B., Kinch M.S., Tice D., Sood A.K. Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer. Neoplasia 2008, 10:1259-1267.
25. Carreiras F., Rigot V., Cruet S., Andre F., Gauduchon P., Marvaldi J. Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin. Int. J. Cancer 1999, 80:285-294.
26. Leroy-Dudal J., Heyman L., Gauduchon P., Carreiras F. Adhesion of human ovarian adenocarcinoma IGROV1 cells to endothelial cells is partly mediated by the alphav integrins-vitronectin adhesive system and induces an alteration of endothelial integrity. Cell. Biol. Int. 2005, 29:482-488.
27. Reuning U. Integrin αvβ3 promotes vitronectin gene expression in human ovarian cancer cells by implicating rel transcription factors. J. Cell Biochem. 2011, 112:1909-1919.
28. Basu A., Tu H. Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta. Biochem. Biophys. Res. Commun. 2005, 334:1068-1073.
29. Simonin K., Brotin E., Dufort S., Dutoit S., Goux D., N'Diaye M., Denoyelle C., Gauduchon P., Poulain L. Mcl-1 is an important determinant of the apoptotic response to the BH3-mimetic molecule HA14-1 in cisplatin-resistant ovarian carcinoma cells. Mol. Cancer Ther. 2009, 8:3162-3170.
30. Tang M.K., Zhou H.Y., Yam J.W., Wong A.S. c-Met overexpression contributes to the acquired apoptotic resistance of nonadherent ovarian cancer cells through a cross talk mediated by phosphatidylinositol 3-kinase and extracellular signal-regulated kinase 1/2. Neoplasia 2010, 12:128-138.
31. Bulavin D.V., Fornace A.J. p38 MAP kinase's emerging role as a tumor suppressor. Adv. Cancer Res. 2004, 92:95-118.
32. Adam A.P., George A., Schewe D., Bragado P., Iglesias B.V., Ranganathan A.C., Kourtidis A., Conklin D.S., Aguirre-Ghiso J.A. Computational identification of a p38SAPK-regulated transcription factor network required for tumor cell quiescence. Cancer Res. 2009, 69:5664-5672.
33. Sosa M.S., Avivar-Valderas A., Bragado P., Wen H.C., Aguirre-Ghiso J.A. ERK1/2 and p38alpha/beta signaling in tumor cell quiescence: opportunities to control dormant residual disease. Clin. Cancer Res. 2011, 17:5850-5857.
34. Ranganathan A.C., Zhang L., Adam A.P., Aguirre-Ghiso J.A. Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res. 2006, 66:1702-1711.
35. Nazarenko I., Jenny M., Keil J., Gieseler C., Weisshaupt K., Sehouli J., Legewie S., Herbst L., Weichert W., Darb-Esfahani S., Dietel M., Schafer R., Ueberall F., Sers C. Atypical protein kinase C zeta exhibits a proapoptotic function in ovarian cancer. Mol. Cancer Res. 2010, 8:919-934.
36. Wu X., Zhu M., Fletcher J.A., Giobbie-Hurder A., Hodi F.S. The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma. PLoS One 2012, 7:e29622.
37. Jorgensen K., Skrede M., Cruciani V., Mikalsen S.O., Slipicevic A., Florenes V.A. Phorbol ester phorbol-12-myristate-13-acetate promotes anchorage-independent growth and survival of melanomas through MEK-independent activation of ERK1/2. Biochem. Biophys. Res. Commun. 2005, 329:266-274.
38. Garcia-Bermejo M.L., Leskow F.C., Fujii T., Wang Q., Blumberg P.M., Ohba M., Kuroki T., Han K.C., Lee J., Marquez V.E., Kazanietz M.G. Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha. J. Biol. Chem. 2002, 277:645-655.
39. Gavrielides M.V., Frijhoff A.F., Conti C.J., Kazanietz M.G. Protein kinase C and prostate carcinogenesis: targeting the cell cycle and apoptotic mechanisms. Curr. Drug Targets 2004, 5:431-443.
40. Powell C.T., Brittis N.J., Stec D., Hug H., Heston W.D., Fair W.R. Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol-13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ. 1996, 7:419-428.
41. Aziz M.H., Manoharan H.T., Church D.R., Dreckschmidt N.E., Zhong W., Oberley T.D., Wilding G., Verma A.K. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer. Cancer Res. 2007, 67:8828-8838.
42. Meshki J., Caino M.C., von Burstin V.A., Griner E., Kazanietz M.G. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway. J. Biol. Chem. 2010, 285:26033-26040.
43. Fernandez C., Ramos A.M., Sancho P., Amran D., de Blas E., Aller P. 12-O-tetradecanoylphorbol-13-acetate may both potentiate and decrease the generation of apoptosis by the antileukemic agent arsenic trioxide in human promonocytic cells. Regulation by extracellular signal-regulated protein kinases and glutathione. J. Biol. Chem. 2004, 279:3877-3884.
44. Mauro A., Ciccarelli C., De Cesaris P., Scoglio A., Bouche M., Molinaro M., Aquino A., Zani B.M. PKCalpha-mediated ERK, JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 2002, 115:3587-3599.
45. Park M.J., Park I.C., Lee H.C., Woo S.H., Lee J.Y., Hong Y.J., Rhee C.H., Lee Y.S., Lee S.H., Shim B.S., Kuroki T., Hong S.I. Protein kinase C-alpha activation by phorbol ester induces secretion of gelatinase B/MMP-9 through ERK1/2 pathway in capillary endothelial cells. Int. J. Oncol. 2003, 22:137-143.
46. Shield K., Riley C., Quinn M.A., Rice G.E., Ackland M.L., Ahmed N. Alpha2beta1 integrin affects metastatic potential of ovarian carcinoma spheroids by supporting disaggregation and proteolysis. J. Carcinog. 2007, 6:11.
47. Townsend P.A., Villanova I., Uhlmann E., Peyman A., Knolle J., Baron R., Teti A., Horton M.A. An antisense oligonucleotide targeting the alphaV integrin gene inhibits adhesion and induces apoptosis in breast cancer cells. Eur. J. Cancer 2000, 36:397-409.
48. Morozevich G.E., Kozlova N.I., Chubukina A.N., Berman A.E. Role of integrin alphavbeta3 in substrate-dependent apoptosis of human intestinal carcinoma cells. Biochemistry (Mosc) 2003, 68:416-423.
49. Uhm J.H., Dooley N.P., Kyritsis A.P., Rao J.S., Gladson C.L. Vitronectin, a glioma-derived extracellular matrix protein, protects tumor cells from apoptotic death. Clin. Cancer Res. 1999, 5:1587-1594.